Cargando…

EDTA Chelation Therapy for the Treatment of Neurotoxicity

Neurotoxicity can be caused by numerous direct agents, of which toxic metals, organophosphorus pesticides, air pollution, radiation and electromagnetic fields, neurotoxins, chemotherapeutic and anesthetic drugs, and pathogens are the most important. Other indirect causes of neurotoxicity are cytokin...

Descripción completa

Detalles Bibliográficos
Autores principales: Fulgenzi, Alessandro, Ferrero, Maria Elena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6429616/
https://www.ncbi.nlm.nih.gov/pubmed/30813622
http://dx.doi.org/10.3390/ijms20051019
_version_ 1783405628878749696
author Fulgenzi, Alessandro
Ferrero, Maria Elena
author_facet Fulgenzi, Alessandro
Ferrero, Maria Elena
author_sort Fulgenzi, Alessandro
collection PubMed
description Neurotoxicity can be caused by numerous direct agents, of which toxic metals, organophosphorus pesticides, air pollution, radiation and electromagnetic fields, neurotoxins, chemotherapeutic and anesthetic drugs, and pathogens are the most important. Other indirect causes of neurotoxicity are cytokine and/or reactive oxygen species production and adoptive immunotherapy. The development of neurodegenerative diseases has been associated with neurotoxicity. Which arms are useful to prevent or eliminate neurotoxicity? The chelating agent calcium disodium ethylenediaminetetraacetic acid (EDTA)—previously used to treat cardiovascular diseases—is known to be useful for the treatment of neurodegenerative diseases. This review describes how EDTA functions as a therapeutic agent for these diseases. Some case studies are reported to confirm our findings.
format Online
Article
Text
id pubmed-6429616
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-64296162019-04-10 EDTA Chelation Therapy for the Treatment of Neurotoxicity Fulgenzi, Alessandro Ferrero, Maria Elena Int J Mol Sci Review Neurotoxicity can be caused by numerous direct agents, of which toxic metals, organophosphorus pesticides, air pollution, radiation and electromagnetic fields, neurotoxins, chemotherapeutic and anesthetic drugs, and pathogens are the most important. Other indirect causes of neurotoxicity are cytokine and/or reactive oxygen species production and adoptive immunotherapy. The development of neurodegenerative diseases has been associated with neurotoxicity. Which arms are useful to prevent or eliminate neurotoxicity? The chelating agent calcium disodium ethylenediaminetetraacetic acid (EDTA)—previously used to treat cardiovascular diseases—is known to be useful for the treatment of neurodegenerative diseases. This review describes how EDTA functions as a therapeutic agent for these diseases. Some case studies are reported to confirm our findings. MDPI 2019-02-26 /pmc/articles/PMC6429616/ /pubmed/30813622 http://dx.doi.org/10.3390/ijms20051019 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Fulgenzi, Alessandro
Ferrero, Maria Elena
EDTA Chelation Therapy for the Treatment of Neurotoxicity
title EDTA Chelation Therapy for the Treatment of Neurotoxicity
title_full EDTA Chelation Therapy for the Treatment of Neurotoxicity
title_fullStr EDTA Chelation Therapy for the Treatment of Neurotoxicity
title_full_unstemmed EDTA Chelation Therapy for the Treatment of Neurotoxicity
title_short EDTA Chelation Therapy for the Treatment of Neurotoxicity
title_sort edta chelation therapy for the treatment of neurotoxicity
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6429616/
https://www.ncbi.nlm.nih.gov/pubmed/30813622
http://dx.doi.org/10.3390/ijms20051019
work_keys_str_mv AT fulgenzialessandro edtachelationtherapyforthetreatmentofneurotoxicity
AT ferreromariaelena edtachelationtherapyforthetreatmentofneurotoxicity